BRPI0810093A2 - Promotor de formação de nevrite - Google Patents

Promotor de formação de nevrite

Info

Publication number: BRPI0810093A2
Authority: BR; Brazil
Prior art keywords: nevrite; formation promoter; promoter; formation; nevrite formation
Prior art date: 2007-04-20

Application number

BRPI0810093-4A2A

Other languages

English (en)

Inventor

Chiho Yabuta

Fumiko Yano

Mitsuyoshi Azuma

Original Assignee

Senju Pharma Co

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-20

Filing date

2008-04-18

Publication date

2014-10-21

2008-04-18 Application filed by Senju Pharma Co, Astellas Pharma Inc filed Critical Senju Pharma Co

2014-10-21 Publication of BRPI0810093A2 publication Critical patent/BRPI0810093A2/pt

Links

230000015572 biosynthetic process Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0810093-4A2A 2007-04-20 2008-04-18 Promotor de formação de nevrite BRPI0810093A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2007112248		2007-04-20
PCT/JP2008/057583 WO2008133198A1 (ja)	2007-04-20	2008-04-18	神経突起形成促進剤

Publications (1)

Publication Number	Publication Date
BRPI0810093A2 true BRPI0810093A2 (pt)	2014-10-21

Family

ID=39925652

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0810093-4A2A BRPI0810093A2 (pt)	2007-04-20	2008-04-18	Promotor de formação de nevrite

Country Status (11)

Country	Link
US (1)	US8637544B2 (pt)
EP (1)	EP2157082B1 (pt)
JP (1)	JP5179477B2 (pt)
KR (1)	KR101486605B1 (pt)
CN (2)	CN103251592B (pt)
BR (1)	BRPI0810093A2 (pt)
CA (1)	CA2684561C (pt)
ES (1)	ES2577539T3 (pt)
MX (1)	MX2009011250A (pt)
RU (1)	RU2442582C2 (pt)
WO (1)	WO2008133198A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3284475B1 (en) *	2015-04-17	2023-11-01	The University of Tokyo	Agent for prevention or treatment of corneal disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPP818099A0 (en)	1999-01-14	1999-02-11	Fujisawa Pharmaceutical Co., Ltd.	New n-containing heterocyclic compounds
US6344358B1 (en)	1999-05-28	2002-02-05	Fujisawa Pharmaceutical Co., Ltd.	Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
ITRM20010755A1 (it)	2001-12-20	2003-06-20	Simonelli Giuseppe	Uso del chinone q10 per il trattamento delle malattie oculari.
CN1658879A (zh) *	2002-04-10	2005-08-24	藤泽药品工业株式会社	神经营养因子产生促进剂
EP1566184A4 (en) *	2002-10-31	2006-07-05	Senju Pharma Co	REMEDY FOR THE TREATMENT OF CORNEAL DISEASE
CN100413538C (zh) *	2002-10-31	2008-08-27	千寿制药株式会社	角膜疾病治疗剂
JP4453642B2 (ja)	2005-10-19	2010-04-21	日産自動車株式会社	駆動系の制振制御装置
CA2643199A1 (en) *	2006-03-08	2007-09-13	Braincells, Inc.	Modulation of neurogenesis by nootropic agents

2008
- 2008-04-18 US US12/596,581 patent/US8637544B2/en not_active Expired - Fee Related
- 2008-04-18 ES ES08740638.5T patent/ES2577539T3/es active Active
- 2008-04-18 CA CA2684561A patent/CA2684561C/en active Active
- 2008-04-18 KR KR1020097024102A patent/KR101486605B1/ko not_active Expired - Fee Related
- 2008-04-18 EP EP08740638.5A patent/EP2157082B1/en active Active
- 2008-04-18 MX MX2009011250A patent/MX2009011250A/es active IP Right Grant
- 2008-04-18 CN CN201310119415.6A patent/CN103251592B/zh active Active
- 2008-04-18 WO PCT/JP2008/057583 patent/WO2008133198A1/ja not_active Ceased
- 2008-04-18 JP JP2009511854A patent/JP5179477B2/ja not_active Expired - Fee Related
- 2008-04-18 CN CN2008800212987A patent/CN101687795B/zh active Active
- 2008-04-18 BR BRPI0810093-4A2A patent/BRPI0810093A2/pt not_active Application Discontinuation
- 2008-04-18 RU RU2009142843/15A patent/RU2442582C2/ru active

Also Published As

Publication number	Publication date
KR101486605B1 (ko)	2015-01-26
CN103251592A (zh)	2013-08-21
JP5179477B2 (ja)	2013-04-10
RU2009142843A (ru)	2011-05-27
CA2684561A1 (en)	2008-11-06
RU2442582C2 (ru)	2012-02-20
JPWO2008133198A1 (ja)	2010-07-22
CN101687795A (zh)	2010-03-31
EP2157082A1 (en)	2010-02-24
CN101687795B (zh)	2013-05-08
CA2684561C (en)	2015-06-30
US20100144792A1 (en)	2010-06-10
EP2157082A4 (en)	2011-03-30
KR20090130142A (ko)	2009-12-17
US8637544B2 (en)	2014-01-28
CN103251592B (zh)	2015-07-29
EP2157082B1 (en)	2016-06-08
ES2577539T3 (es)	2016-07-15
WO2008133198A1 (ja)	2008-11-06
MX2009011250A (es)	2009-11-05

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-10-23	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2018-12-18	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-05-21	B25G	Requested change of headquarter approved	Owner name: SENJU PHARMACEUTICAL CO. LTD. (JP) ; ASTELLAS PHAR Owner name: SENJU PHARMACEUTICAL CO. LTD. (JP) ; ASTELLAS PHARMA INC (JP)
2019-07-16	B09B	Patent application refused [chapter 9.2 patent gazette]
2022-07-12	B350	Update of information on the portal [chapter 15.35 patent gazette]

Publication	Publication Date	Title
NO2021036I1 (no)	2021-09-13	Ofatumumab
DK2354233T3 (da)	2015-02-16	Patogen inducerbar syntetisk promotor
NL300788I2 (nl)	2024-03-06	Pembrolizumab
EP2170350A4 (en)	2011-09-28	SUBSTITUTED IMIDAZOHETEROCYCLES
ATE542825T1 (de)	2012-02-15	Substituierte piperidino-dihydrothienopyrimidine
EP2288997A4 (en)	2012-02-15	DISTRIBUTED CACHE ARRANGEMENT
BRPI0821573A2 (pt)	2016-08-09	benzofuropirimidonas
ATE501136T1 (de)	2011-03-15	Imidazopyridinone
ATE514696T1 (de)	2011-07-15	Diphenyl-dihydro-imidazopyridinone
BRPI0811451A2 (pt)	2014-11-04	Exopolissacarídeo
BRPI0814519A2 (pt)	2014-09-30	Organopolissiloxano
BRPI0815547A2 (pt)	2015-02-10	Depsipeptídeos cícliocos
BRPI0812840A2 (pt)	2014-12-09	2-imidazolinas
FI20075851A0 (fi)	2007-11-28	Muodostusosa
BRPI0812994A2 (pt)	2014-12-23	Microbiocidas
BRPI0816334A2 (pt)	2015-03-31	Corrimão modificado
EP2318537A4 (en)	2012-01-18	OPTIMIZED PROMOTER SEQUENCE
BRPI0922716A2 (pt)	2016-11-01	purificação de polipeptídeo
DE112008001216A5 (de)	2010-02-04	Magnetronplasmaanlage
FI20075057A0 (fi)	2007-01-26	Mäntähydraulimoottori
DK2195435T3 (da)	2012-12-10	Trichoderma-promoter
BRPI0806971A2 (pt)	2014-04-08	Promotores induzíveis pela deficiência de água
DE112008002200A5 (de)	2010-09-23	Sperrsynchronisiervorrichtung
CU20090155A7 (es)	2011-04-26	Macrolidos
DE112008001534A5 (de)	2010-03-18	Anreihgussform